Search Results | The Journal of Immunology | American Association of Immunologists

1-20 of 73

2 3 4

Sort by

Sort Order Select

Journal Articles

Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells

Abraham Sachs, Eugene Moore, Zeynep Kosaloglu-Yalcin, Bjoern Peters, John Sidney, Steven A. Rosenberg, Paul F. Robbins, Alessandro Sette

J Immunol (2020) 205 (2): 539–549.

DOI: https://doi.org/10.4049/jimmunol.1901173

Published: 15 July 2020

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

High affinity oligoclonal TCRs define effective adoptive T-cell therapy targeting mutant KRAS-G12D

Malcolm John Wyness Sim, Jinghua Lu, Matthew Spencer, Francis Hopkins, Eric Tran, Steven A Rosenberg, Eric O Long, Peter Daopin Sun

J Immunol (2020) 204 (1_Supplement): 239.11.

DOI: https://doi.org/10.4049/jimmunol.204.Supp.239.11

Published: 01 May 2020

View article

Add to Citation Manager

Journal Articles

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong-Chen Lu

J Immunol (2019) 202 (12): 3458–3467.

DOI: https://doi.org/10.4049/jimmunol.1801022

Published: 15 June 2019

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Substitution of alpha aminobutyric acid for cysteine at class I MHC anchor positions can enhance recognition of cancer epitopes

Abraham E Sachs, Bjoern Peters, John Sidney, Alessandro Sette, Steven A Rosenberg, Paul F Robbins

J Immunol (2019) 202 (1_Supplement): 134.11.

DOI: https://doi.org/10.4049/jimmunol.202.Supp.134.11

Published: 01 May 2019

View article

Add to Citation Manager

Journal Articles

A rapid single-cell RNA-seq approach to identify neoantigen-specific T-cell receptors targeting tumor-specific mutations for use in gene-engineered T-cell immunotherapy

Yong-Chen William Lu, Zhili Zheng, Paul F Robbins, Eric Tran, Todd D Prickett, Jared J Gartner, Yong F Li, Satyajit Ray, Valery Bliskovsky, Peter C Fitzgerald, Steven A Rosenberg

J Immunol (2017) 198 (1_Supplement): 126.14.

DOI: https://doi.org/10.4049/jimmunol.198.Supp.126.14

Published: 01 May 2017

View article

Add to Citation Manager

Journal Articles

Specific Increase in Potency via Structure-Based Design of a TCR

Karolina Malecek, Arsen Grigoryan, Shi Zhong, Wei Jun Gu, Laura A. Johnson, Steven A. Rosenberg, Timothy Cardozo, Michelle Krogsgaard

J Immunol (2014) 193 (5): 2587–2599.

DOI: https://doi.org/10.4049/jimmunol.1302344

Published: 01 September 2014

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

IL-2: The First Effective Immunotherapy for Human Cancer

In Special Collection:

Translating Immunology

Steven A. Rosenberg

J Immunol (2014) 192 (12): 5451–5458.

DOI: https://doi.org/10.4049/jimmunol.1490019

Published: 15 June 2014

View article

Add to Citation Manager

Journal Articles

Structure-Based Design of Altered MHC Class II–Restricted Peptide Ligands with Heterogeneous Immunogenicity

Shuming Chen, Yili Li, Florence R. Depontieu, Tracee L. McMiller, A. Michelle English, Jeffrey Shabanowitz, Ferdynand Kos, John Sidney, Alessandro Sette, Steven A. Rosenberg, Donald F. Hunt, Roy A. Mariuzza, Suzanne L. Topalian

J Immunol (2013) 191 (10): 5097–5106.

DOI: https://doi.org/10.4049/jimmunol.1300467

Published: 15 November 2013

View article

Add to Citation Manager

Journal Articles

Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy

Simon Turcotte, Alena Gros, Katherine Hogan, Eric Tran, Christian S. Hinrichs, John R. Wunderlich, Mark E. Dudley, Steven A. Rosenberg

J Immunol (2013) 191 (5): 2217–2225.

DOI: https://doi.org/10.4049/jimmunol.1300538

Published: 01 September 2013

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression

Yong-Chen Lu, Xin Yao, Yong F. Li, Mona El-Gamil, Mark E. Dudley, James C. Yang, Jorge R. Almeida, Daniel C. Douek, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins

J Immunol (2013) 190 (12): 6034–6042.

DOI: https://doi.org/10.4049/jimmunol.1202830

Published: 15 June 2013

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer

Nachimuthu Chinnasamy, Jennifer A. Wargo, Zhiya Yu, Mahadev Rao, Timothy L. Frankel, John P. Riley, Jenny J. Hong, Maria R. Parkhurst, Steven A. Feldman, David S. Schrump, Nicholas P. Restifo, Paul F. Robbins, Steven A. Rosenberg, Richard A. Morgan

J Immunol (2011) 186 (2): 685–696.

DOI: https://doi.org/10.4049/jimmunol.1001775

Published: 15 January 2011

View article

Add to Citation Manager

Journal Articles

Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase

Timothy L. Frankel, William R. Burns, Peter D. Peng, Zhiya Yu, Dhanalakshmi Chinnasamy, Jennifer A. Wargo, Zhili Zheng, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan

J Immunol (2010) 184 (11): 5988–5998.

DOI: https://doi.org/10.4049/jimmunol.1000189

Published: 01 June 2010

View article

Add to Citation Manager

Journal Articles

A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity

Yangbing Zhao, Qiong J. Wang, Shicheng Yang, James N. Kochenderfer, Zhili Zheng, Xiaosong Zhong, Michel Sadelain, Zelig Eshhar, Steven A. Rosenberg, Richard A. Morgan

J Immunol (2009) 183 (9): 5563–5574.

DOI: https://doi.org/10.4049/jimmunol.0900447

Published: 01 November 2009

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

Paul F. Robbins, Yong F. Li, Mona El-Gamil, Yangbing Zhao, Jennifer A. Wargo, Zhili Zheng, Hui Xu, Richard A. Morgan, Steven A. Feldman, Laura A. Johnson, Alan D. Bennett, Steven M. Dunn, Tara M. Mahon, Bent K. Jakobsen, Steven A. Rosenberg

J Immunol (2008) 180 (9): 6116–6131.

DOI: https://doi.org/10.4049/jimmunol.180.9.6116

Published: 01 May 2008

View article

Add to Citation Manager

Journal Articles

High-Affinity TCRs Generated by Phage Display Provide CD4⁺ T Cells with the Ability to Recognize and Kill Tumor Cell Lines

Yangbing Zhao, Alan D. Bennett, Zhili Zheng, Qiong J. Wang, Paul F. Robbins, Lawrence Y. L. Yu, Yi Li, Peter E. Molloy, Steven M. Dunn, Bent K. Jakobsen, Steven A. Rosenberg, Richard A. Morgan

J Immunol (2007) 179 (9): 5845–5854.

DOI: https://doi.org/10.4049/jimmunol.179.9.5845

Published: 01 November 2007

View article

Add to Citation Manager

Journal Articles

Administration of a CD25-Directed Immunotoxin, LMB-2, to Patients with Metastatic Melanoma Induces a Selective Partial Reduction in Regulatory T Cells In Vivo

Daniel J. Powell, Jr., Aloisio Felipe-Silva, Maria J. Merino, Mojgan Ahmadzadeh, Tamika Allen, Catherine Levy, Donald E. White, Sharon Mavroukakis, Robert J. Kreitman, Steven A. Rosenberg, Ira Pastan

J Immunol (2007) 179 (7): 4919–4928.

DOI: https://doi.org/10.4049/jimmunol.179.7.4919

Published: 01 October 2007

View article

Add to Citation Manager

Journal Articles

Memory T cells in the tumor-infiltrating lymphocytes for adoptive cell transfer therapy (B145)

Juhua Zhou, Prakash Nagarkatti, Paul F Robbins, Steven A Rosenberg, Mitzi Nagarkatti

J Immunol (2007) 178 (1_Supplement): LB30.

DOI: https://doi.org/10.4049/jimmunol.178.Supp.B145

Published: 01 April 2007

View article

Add to Citation Manager

Journal Articles

Adoptive Transfer of Vaccine-Induced Peripheral Blood Mononuclear Cells to Patients with Metastatic Melanoma following Lymphodepletion

Daniel J. Powell, Jr., Mark E. Dudley, Katherine A. Hogan, John R. Wunderlich, Steven A. Rosenberg

J Immunol (2006) 177 (9): 6527–6539.

DOI: https://doi.org/10.4049/jimmunol.177.9.6527

Published: 01 November 2006

View article

Add to Citation Manager

Journal Articles

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Laura A. Johnson, Bianca Heemskerk, Daniel J. Powell, Jr., Cyrille J. Cohen, Richard A. Morgan, Mark E. Dudley, Paul F. Robbins, Steven A. Rosenberg

J Immunol (2006) 177 (9): 6548–6559.

DOI: https://doi.org/10.4049/jimmunol.177.9.6548

Published: 01 November 2006

View article

Add to Citation Manager

Journal Articles

Modulation by IL-2 of CD70 and CD27 Expression on CD8⁺ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy

Jianping Huang, Keith W. Kerstann, Mojgan Ahmadzadeh, Yong F. Li, Mona El-Gamil, Steven A. Rosenberg, Paul F. Robbins

J Immunol (2006) 176 (12): 7726–7735.

DOI: https://doi.org/10.4049/jimmunol.176.12.7726

Published: 15 June 2006

View article

Add to Citation Manager

2 3 4

NARROW

Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells

High affinity oligoclonal TCRs define effective adoptive T-cell therapy targeting mutant KRAS-G12D

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

Substitution of alpha aminobutyric acid for cysteine at class I MHC anchor positions can enhance recognition of cancer epitopes

A rapid single-cell RNA-seq approach to identify neoantigen-specific T-cell receptors targeting tumor-specific mutations for use in gene-engineered T-cell immunotherapy

Specific Increase in Potency via Structure-Based Design of a TCR

IL-2: The First Effective Immunotherapy for Human Cancer

Structure-Based Design of Altered MHC Class II–Restricted Peptide Ligands with Heterogeneous Immunogenicity

Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy

Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression

A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer

Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase

A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

High-Affinity TCRs Generated by Phage Display Provide CD4⁺ T Cells with the Ability to Recognize and Kill Tumor Cell Lines

Administration of a CD25-Directed Immunotoxin, LMB-2, to Patients with Metastatic Melanoma Induces a Selective Partial Reduction in Regulatory T Cells In Vivo

Memory T cells in the tumor-infiltrating lymphocytes for adoptive cell transfer therapy (B145)

Adoptive Transfer of Vaccine-Induced Peripheral Blood Mononuclear Cells to Patients with Metastatic Melanoma following Lymphodepletion

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Modulation by IL-2 of CD70 and CD27 Expression on CD8⁺ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only